On April 7, 2014, CONMED Corporation (NASDAQ:CNMD), announced that it expects to report first quarter 2014 financial results before the market opens on Thursday, April 24, 2014, and will also hold a conference call live over the Internet at 10:00 a.m. Eastern Time that same day. This webcast can be accessed from CONMED’s web site at www.conmed.com . Replays of the call will be made available through May 2, 2014. CONMED Corporation (NASDAQ:CNMD), shares after opening at $42.26 moved to $45.54 on last trade day and at the end of the day closed at $45.25. Company price to sales ratio in past twelve months was calculated as 1.61 and price to cash ratio as 22.63. CONMED Corporation (NASDAQ:CNMD), showed a positive weekly performance of 4.60%.
Flamel Technologies S.A. (ADR) (NASDAQ:FLML), saw a big move in the last trading session, as the company’s shares fell by nearly 14% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent trend of the company, as the stock is now trading within the volatile price range of $10.62 to $14.70 in the past one-month time frame. Flamel Technologies S.A. (ADR) (NASDAQ:FLML), shares fell 9.72% in last trading session and ended the day on $9.94. Flamel Technologies S.A. (ADR) (NASDAQ:FLML), return on equity ratio is recorded as -584.30% and its return on assets is -32.80%. Flamel Technologies S.A. (ADR) (NASDAQ:FLML), yearly performance is 109.26%.
MacroGenics (NASDAQ:MGNX) had its target price lifted by Stifel Nicolaus from $51.00 to $53.00 in a research note released on Friday morning, Analyst RN reports. MacroGenics Inc (NASDAQ:MGNX), shares moved down 2.88% in last trading session and was closed at $19.58, while trading in range of $ 18.35 – 20.49. MacroGenics Inc (NASDAQ:MGNX), year to date (YTD) performance is -28.62%.
ANI Pharmaceuticals (NASDAQ:ANIP) Director Tracy Marshbanks sold 21,767 shares of ANI Pharmaceuticals stock on the open market in a transaction dated Friday, March 21st. The shares were sold at an average price of $31.42, for a total value of $683,919.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. ANI Pharmaceuticals Inc (NASDAQ:ANIP), weekly performance is -22.84%. On last trading day company shares ended up $21.62. ANI Pharmaceuticals Inc (NASDAQ:ANIP), distance from 50-day simple moving average (SMA50) is -25.12%. Analysts mean target Price for the company is $38.00.